Arandomized, double-blind, placebo-controlled Phase 3 study of darolutamide plus androgen deprivationtherapy (ADT) compared with placebo plus ADT in patients with high-risk biochemical recurrence (BCR) ofprostate cancer

Project: Research project

Fingerprint

Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.

Medicine & Life Sciences